Cargando…

Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway

BACKGROUND: Tribbles pseudokinase 3 (TRIB3) protein is a pseudokinase which plays an important role in cellular stress, metabolism, and tumor progression. However, the expression and function of TRIB3 in ovarian cancer is unknown. METHODS: TRIB3 expression was detected by immunohistochemistry in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shuang, Wang, Caixia, Li, Xiao, Hu, Yuexin, Gou, Rui, Guo, Qian, Nie, Xin, Liu, Juanjuan, Zhu, Liancheng, Lin, Bei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456033/ https://www.ncbi.nlm.nih.gov/pubmed/32874132 http://dx.doi.org/10.1186/s12935-020-01509-z

Ejemplares similares

YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K/AKT and MAPK pathways
por: Li, Xiao, et al.
Publicado: (2021)

Keratin 80 regulated by miR-206/ETS1 promotes tumor progression via the MEK/ERK pathway in ovarian cancer
por: Liu, Ouxuan, et al.
Publicado: (2021)

Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells
por: Wang, Jing, et al.
Publicado: (2019)

ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15
por: Wang, Shuang, et al.
Publicado: (2020)

Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments
por: Gao, Lingling, et al.
Publicado: (2020)

Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways
por: Zhang, Ya-Jun, et al.
Publicado: (2018)

Identification of long noncoding RNA RP11-89K21.1 and RP11-357H14.17 as prognostic signature of endometrial carcinoma via integrated bioinformatics analysis
por: Gao, Lingling, et al.
Publicado: (2020)

Identification of the prognostic value of a 2-gene signature of the WNT gene family in UCEC using bioinformatics and real-world data
por: Hu, Yuexin, et al.
Publicado: (2021)

Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway
por: Niu, Chang-Chun, et al.
Publicado: (2014)

UBTF facilitates melanoma progression via modulating MEK1/2-ERK1/2 signalling pathways by promoting GIT1 transcription
por: Zhang, Jian, et al.
Publicado: (2021)

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
por: Gou, Rui, et al.
Publicado: (2022)

Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
por: Gou, Rui, et al.
Publicado: (2019)

Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs
por: Haas, Bodo, et al.
Publicado: (2018)

CLDN2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin/ERK signaling pathway
por: Zhang, Xiaowei, et al.
Publicado: (2018)

Sevoflurane inhibits the progression of ovarian cancer through down-regulating stanniocalcin 1 (STC1)
por: Zhang, Chuanfeng, et al.
Publicado: (2019)

MiR-155-5p suppresses SOX1 to promote proliferation of cholangiocarcinoma via RAF/MEK/ERK pathway
por: Wang, Da, et al.
Publicado: (2021)

SERPIND1 Affects the Malignant Biological Behavior of Epithelial Ovarian Cancer via the PI3K/AKT Pathway: A Mechanistic Study
por: Guo, Qian, et al.
Publicado: (2019)

Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR/RAS/RAF/MEK/ERK signaling pathway
por: Wu, Dongdong, et al.
Publicado: (2019)

Interaction of HE4 and ANXA2 exists in various malignant cells—HE4–ANXA2–MMP2 protein complex promotes cell migration
por: Wang, Jing, et al.
Publicado: (2019)

Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target
por: Fernandez, Marta Llaurado, et al.
Publicado: (2019)

Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma
por: Zheng, Mingjun, et al.
Publicado: (2019)

BCKDK Promotes Ovarian Cancer Proliferation and Migration by Activating the MEK/ERK Signaling Pathway
por: Li, Huashun, et al.
Publicado: (2022)

Circ_0032821 acts as an oncogene in cell proliferation, metastasis and autophagy in human gastric cancer cells in vitro and in vivo through activating MEK1/ERK1/2 signaling pathway
por: Jiang, Yuanyuan, et al.
Publicado: (2020)

Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway
por: Ren, Li-Xin, et al.
Publicado: (2021)

Knockdown of ALPK2 inhibits the development and progression of Ovarian Cancer
por: Zhu, Xiaogang, et al.
Publicado: (2020)

MEK inhibition induced downregulation of MRP1 and MRP3 expression in experimental hepatocellular carcinoma
por: Lin, Shibo, et al.
Publicado: (2013)

PICALM exerts a role in promoting CRC progression through ERK/MAPK signaling pathway
por: Zhang, Xitao, et al.
Publicado: (2022)

miR-223-3p inhibits the progression of atherosclerosis via down-regulating the activation of MEK1/ERK1/2 in macrophages
por: You, Daofeng, et al.
Publicado: (2022)

TRIB3 inhibits proliferation and promotes osteogenesis in hBMSCs by regulating the ERK1/2 signaling pathway
por: Zhang, Cui, et al.
Publicado: (2017)

TRIB3 Promotes Lung Adenocarcinoma Progression via an Enhanced Warburg Effect
por: Xing, Yutong, et al.
Publicado: (2020)

Identification of immune‐enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma
por: Zheng, Mingjun, et al.
Publicado: (2020)

TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways
por: Singh, Karnika, et al.
Publicado: (2023)

Ovarian cyst removal influences ovarian reserve dependent on histology, size and type of operation
por: Henes, Melanie, et al.
Publicado: (2018)

RAD21 Confers Poor Prognosis and Affects Ovarian Cancer Sensitivity to Poly(ADP-Ribose)Polymerase Inhibitors Through DNA Damage Repair
por: Gou, Rui, et al.
Publicado: (2022)

Protopine triggers apoptosis via the intrinsic pathway and regulation of ROS/PI3K/Akt signalling pathway in liver carcinoma
por: Nie, Chunhui, et al.
Publicado: (2021)

Down regulation of G protein-coupled receptor 137 expression inhibits proliferation and promotes apoptosis in leukemia cells
por: Men, Li-Jie, et al.
Publicado: (2018)

Circ_0000190 suppresses gastric cancer progression potentially via inhibiting miR-1252/PAK3 pathway
por: Wang, Gui-Jun, et al.
Publicado: (2020)

CC Chemokine 2 Promotes Ovarian Cancer Progression through the MEK/ERK/MAP3K19 Signaling Pathway
por: Liu, Wei, et al.
Publicado: (2023)

Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc
por: Luo, Haitao, et al.
Publicado: (2010)

The ionophore antibiotic gramicidin A inhibits pancreatic cancer stem cells associated with CD47 down-regulation
por: Wang, Rui-Qi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tqftuacp80c91q31fho1gbvsra